Identification of a ubiquitin-ligase which recognizes oxidized proteins.
Identification of a ubiquitin-ligase which recognizes oxidized proteins.
批准号:
11680630
负责人:
IWAI Kazuhiro
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have been shown that the RNA binding protein, iron regulatory protein 2 (IRP2), which is known to be a master regulator of iron metabolism, is degraded by proteasome in the presence of iron. We have also shown that oxidation of the protein by iron creates the signal for the ubiquitination of IRP2 prior to its degradation. In the present study, we tried to identify the mode of iron binding to IRP2, the oxidative modification of IRP2 provoked by iron and ubiquitin-ligase (E3) recognizing oxidized IRP2. We identified that aluminum stabilizes IRP2 by inhibiting iron-induced oxidation of the protein competitively, which suggest that iron binding site (s) are present in IRP2 and that aluminum can bind to the iron binding site of IRP2 competitively to iron. Considering that organisms have not been encountered to aluminum during the evolution, they acquired the metal binding site that is highly selective to iron. Now, we are analyzing the exact nature of the iron binding site. Although we have not published yet, we have found that the IDD domain protein, which domain is necessary for the iron-dependent degradation of IRP2, can bind to E3 for IRP2 in an iron-dependent manner. In other word, the IDD domain serves as the site of iron binding, oxidized by iron and recognized by E3 for IRP2. We are currently identifying E3 for IRP2 by using this assay system. Moreover, we have been identified that Familial Parkinson's disease gene product, Parkin, is a ubiquitin-protein ligase together with Professor Y.Mizuno at Juntendo University and Dr. K.Tanaka at Tokyo Metropolitan Institute of Medical Science.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Iwai,K., et al.: "Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cb1/Sli-1."Molecular Cell.. 4. 1029-1040 (1999)
Iwai,K. 等人:“泛素连接酶活性和酪氨酸磷酸化是 c-Cb1/Sli-1 抑制生长因子信号传导的基础。”Molecular Cell.. 4. 1029-1040 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sadot,E., et al.: "Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system."Oncogene. 19. 1992-2001 (2000)
Sadot,E. 等人:“斑珠蛋白和 β-连环蛋白与泛素蛋白酶体系统的不同相互作用。”癌基因。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shimura H. et al.: "Familial parkinson's disease gene product, Parkin, is a ubiquitinprotein ligase"Nature Genet.. 25. 302-305 (2000)
Shimura H.等:“家族性帕金森病基因产物Parkin是一种泛素蛋白连接酶”Nature Genet.. 25. 302-305 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Iwai,K., et al.: "Targeted deletion of iron regulatory protein 2 causes iron overload and neurodegenerative disease in mice."Nature Genet.. 27. 209-214 (2001)
Iwai,K., et al.:“铁调节蛋白 2 的靶向删除会导致小鼠铁过载和神经退行性疾病。”Nature Genet.. 27. 209-214 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
岩井一宏 他: "pVHLユビキチンリガーゼと発癌"実験医学・増刊号,タンパク質分解の最前線. 19. 142-147 (2001)
Kazuhiro Iwai 等人:“pVHL 泛素连接酶和致癌作用”实验医学特刊,蛋白质降解前沿 19. 142-147 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 17 条
Patho-physiological function of the ubiquitin ligase that generates linear ubiquitin chains (LUBAC)
-
批准号:25253019
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$29.87万
-
财政年份:2013
-
负责人:IWAI Kazuhiro
-
依托单位:
Development of regulators of the LUBAC ubiquitin ligase that modulate NF-kappaB activation
-
批准号:24659136
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:IWAI Kazuhiro
-
依托单位:
Analysis of pathophysiology of LUBAC mediated NF-kappaB activation
-
批准号:22249008
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.53万
-
财政年份:2010
-
负责人:IWAI Kazuhiro
-
依托单位:
Physiology and pathology of the ubiquitin-mediated quality control system
-
批准号:14GS0322
-
项目类别:Grant-in-Aid for Creative Scientific Research
-
资助金额:$220.9万
-
财政年份:2002
-
负责人:IWAI Kazuhiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
SPOP介导的PDK1泛素化降解通过负调控PI3K/Akt通路抑制前列腺癌发生的机制研究
-
批准号:32100559
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:蒋起韦
-
依托单位:
去泛素化酶USP7通过稳定KRAS促进非小细胞肺癌发生发展的分子机制研究
-
批准号:32100567
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:黄斌
-
依托单位:
OTUB1调控pSTAT3去泛素化影响NSCLC发生发展的机制研究
-
批准号:32100577
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:任莹
-
依托单位:
USP33调控Viperin蛋白泛素化及IFN抗病毒活性的机制研究
-
批准号:32000540
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:袁玉康
-
依托单位:
BRAP泛素连接酶调控NF-κB信号通路的机制研究
-
批准号:31970734
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:金建平
-
依托单位:
线性泛素连接酶HOIP通过Hedgehog信号促进结肠癌细胞增殖和耐药的作用及分子机制
-
批准号:31900559
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:程敏章
-
依托单位:
TRAF3-USP8调节PD-L1 K63多聚泛素化修饰及其在肿瘤免疫治疗中的分子机制研究
-
批准号:31970732
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张金方
-
依托单位:
转录因子IRF3的泛素和SUMO修饰调节机制及其在抗病毒天然免疫中的功能
-
批准号:31130020
-
项目类别:重点项目
-
资助金额:315.0万元
-
批准年份:2011
-
负责人:舒红兵
-
依托单位: